NeuroOne Medical Technologies Corporation Increase (Decrease) in Accrued Liabilities
NeuroOne Medical Technologies Corporation (NMTC) reported Increase (Decrease) in Accrued Liabilities of -$1.67 million for the 6-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-05-12
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities for the quarter ending 2023-03-31 was -$1.36M.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was -$306.13K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was $1.66M, a 1227.97% increase year-over-year.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was $107.20K, a 263.68% increase year-over-year.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities for fiscal 2022 was $1.43M.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities for fiscal 2021 was -$7.48K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities for fiscal 2020 was -$82.35K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities for fiscal 2019 was -$836.87K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2023-03-31 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$1.67M 10-Q · filed 2023-05-12 | -$6.15K derived: sum of 3 quarters · filed 2023-05-12 | $101.05K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2022-12-31 | -$306.13K 10-Q · filed 2023-02-13 | $1.36M derived: sum of 2 quarters · filed 2023-02-13 | $1.46M derived: sum of 3 quarters · filed 2023-02-13 | $1.45M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2022-09-30 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $1.77M derived: sum of 2 quarters · filed 2022-12-22 | $1.75M derived: sum of 3 quarters · filed 2023-05-12 | $1.43M 10-K · filed 2022-12-22 | |
| 2022-06-30 | $107.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $89.14K derived: sum of 2 quarters · filed 2023-05-12 | -$228.31K 10-Q · filed 2022-08-11 | -$103.08K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2022-03-31 | -$18.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$335.52K 10-Q · filed 2023-05-12 | -$210.28K derived: sum of 3 quarters · filed 2023-05-12 | -$180.80K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$317.46K 10-Q · filed 2023-02-13 | -$323.83K 10-Q · filed 2022-02-14 | -$192.22K derived: sum of 2 quarters · filed 2023-02-13 | -$162.74K derived: sum of 3 quarters · filed 2023-02-13 | -$436.25K derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-09-30 | $125.24K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $154.72K derived: sum of 2 quarters · filed 2022-12-22 | -$118.79K derived: sum of 3 quarters · filed 2022-12-22 | -$7.48K 10-K · filed 2022-12-22 | |
| 2021-06-30 | $29.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | -$244.03K derived: sum of 2 quarters · filed 2022-08-11 | -$132.72K 10-Q · filed 2022-08-11 | -$35.77K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$273.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$162.19K 10-Q · filed 2022-05-12 | -$65.25K derived: sum of 3 quarters · filed 2022-05-31 | $109.16K derived: sum of 4 quarters · filed 2022-05-31 | |
| 2020-12-31 | $111.32K 10-Q · filed 2022-02-14 | $208.26K derived: sum of 2 quarters · filed 2022-05-31 | $382.67K derived: sum of 3 quarters · filed 2022-05-31 | $47.11K derived: sum of 4 quarters · filed 2022-05-31 | |
| 2020-09-30 | $96.94K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-31 | $271.35K derived: sum of 2 quarters · filed 2022-05-31 | -$64.20K derived: sum of 3 quarters · filed 2022-05-31 | -$82.35K 10-K/A · filed 2022-05-31 | |
| 2020-06-30 | $174.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | -$161.15K derived: sum of 2 quarters · filed 2021-08-13 | -$179.30K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$335.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | -$353.70K 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | -$18.15K 10-Q · filed 2021-02-16 | ||||
| 2019-09-30 | -$836.87K 10-K · filed 2020-12-09 | ||||
| 2018-09-30 | $437.34K 10-KT · filed 2019-03-18 | ||||
| 2018-03-31 | $246.82K 10-Q · filed 2018-05-16 | $417.94K derived: sum of 2 quarters · filed 2019-03-18 | |||
| 2017-12-31 | $171.12K derived: 10-KT 12 month − 10-KT 9 month · filed 2019-03-18 | $813.22K 10-KT · filed 2019-03-18 | |||
| 2017-09-30 | $642.10K 10-KT · filed 2019-03-18 | ||||
| 2017-03-31 | $107.63K 10-Q · filed 2018-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |